1. An abscopal effect may augment PD-1 inhibition in refractory classical Hodgkin lymphoma. Issue 11 (2nd November 2018) Authors: Wight, Joel C.; Hawkes, Eliza A.; Berlangieri, Salvatore U.; Khor, Richard; Grigg, Andrew P. Journal: Leukemia & lymphoma Issue: Volume 59:Issue 11(2018) Page Start: 2749 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI. Issue 5 (September 2018) Authors: Wight, Joel C.; Chong, Geoffrey; Grigg, Andrew P.; Hawkes, Eliza A. Journal: Blood reviews Issue: Volume 32:Issue 5(2018:Sep.) Page Start: 400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Real-world tolerability of venetoclax-based maintenance therapy with azole antifungal prophylaxis for acute myeloid leukemia in remission. (May 2022) Authors: Nguyen, Phillip C.; Donati, Vanessa; Vassili, Catherine; Grigg, Andrew P.; Tiong, Ing S. Journal: Leukemia research Issue: Volume 116(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The tyrosine kinase inhibitor, nilotinib potentiates a prothrombotic state. Issue 145 (September 2016) Authors: Alhawiti, Naif; Burbury, Kate L.; Kwa, Faith A.; O'Malley, Cindy J.; Shuttleworth, Peter; Alzard, Mohamad; Hamadi, Abdullah; Grigg, Andrew P.; Jackson, Denise E. Journal: Thrombosis research Issue: Issue 145(2016) Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The tyrosine kinase inhibitor, nilotinib potentiates a prothrombotic state. Issue 145 (September 2016) Authors: Alhawiti, Naif; Burbury, Kate L.; Kwa, Faith A.; O'Malley, Cindy J.; Shuttleworth, Peter; Alzard, Mohamad; Hamadi, Abdullah; Grigg, Andrew P.; Jackson, Denise E. Journal: Thrombosis research Issue: Issue 145(2016) Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low‐intensity chemotherapy in acute myeloid leukaemia. (26th May 2020) Authors: Tiong, Ing S.; Dillon, Richard; Ivey, Adam; Teh, Tse‐Chieh; Nguyen, Phillip; Cummings, Nicholas; Taussig, David C.; Latif, Annie‐Louise; Potter, Nicola E.; Runglall, Manohursingh; Russell, Nigel H.; Raj, Kavita; Schwarer, Anthony P.; Fong, Chun Yew; Grigg, Andrew P.; Wei, Andrew H. Journal: British journal of haematology Issue: Volume 192:Number 6(2021) Page Start: 1026 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗